CHU Brugmann   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Brussels Belgium (1923)

Organization Overview

First Clinical Trial
2007
NCT00420277
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

CHU Brugmann | CHU-Brugmann | CHU Brugmann, Brussels | CHU Brugmann Dept Rheumatology, Brussels